Comparative Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 Diabetes

20255 citationsJournal Articlegold Open Access

Authors

Takefumi Kishimori

Takao Kato · Kyoto University

Abstract

Use of GLP1-RA for patients with HF and T2D was associated with reduced 12-month incidence of all-cause death and hospitalization compared with DPP-4i.

Topics & Keywords

Diabetes Treatment and Management Peptidase Inhibition and Analysis Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the American Heart Association

Volume 14, Issue 4, pp. e037510-e037510

DOI: 10.1161/jaha.124.037510

Field-Weighted Citation Impact: 6.27